Softwr

Research · head to head

Chemaxon vs DNAnexus

Chemaxon logo

Chemaxon

Research

Cheminformatics toolkits and structure handling, now a Certara subsidiary

From
On request
Rated
-
Full reviewWebsite
DNAnexus logo

DNAnexus

Research

Regulated cloud platform for genomic and multiomic data, with GxP and FedRAMP coverage

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Chemaxon the October 2024 Certara acquisition ended two decades of vendor neutrality, and organisations that embedded JChem precisely because Chemaxon competed with nobody now depend on a component owned by a company that sells into their accounts.; DNAnexus no pricing is published, so an organisation cannot compare the total cost against running the same pipelines on its own cloud account until it is deep in a sales process.
  • They diverge on capability: Chemaxon covers Marvin, DNAnexus covers Governed data storage.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Chemaxon and DNAnexus actually diverge.

Attributes where Chemaxon and DNAnexus differ
AttributeChemaxonDNAnexus
PlatformsWeb, Windows, macOS, Linux, On-premise, APIWeb, Linux

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Chemaxon

  • Marvin
  • JChem toolkits
  • Calculator Plugins
  • Compound Registration
  • Instant JChem
  • Design Hub
  • Free academic package
  • Embedded redistribution

Only in DNAnexus

  • Governed data storage
  • Workflow execution
  • App building
  • Controlled collaboration
  • Compliance posture
  • Cohort browsing

What people use each for

The jobs each tool is most often brought in to do.

Chemaxon

  • A software vendor embedding a structure sketcher and search into its own product rather than writing chemistry codenot DNAnexus
  • A pharmaceutical informatics team building an internal compound registration system on JChem cartridgesnot DNAnexus
  • A computational chemistry group needing consistent pKa and logD prediction across a screening cascadenot DNAnexus
  • A university teaching cheminformatics that can use the free two-year academic package for a classnot DNAnexus

DNAnexus

  • A clinical diagnostics laboratory that needs a CLIA and CAP aligned environment for production sequencing pipelines without building the compliance evidence itselfnot Chemaxon
  • A pharma sponsor analysing genomic endpoints in a registrational programme where 21 CFR Part 11 records are requirednot Chemaxon
  • A biobank or consortium giving hundreds of external researchers governed access to a dataset too large to distributenot Chemaxon
  • A diagnostics vendor packaging its pipeline as a versioned app so partner laboratories can run it without receiving the source codenot Chemaxon

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Chemaxon

  • The October 2024 Certara acquisition ended two decades of vendor neutrality, and organisations that embedded JChem precisely because Chemaxon competed with nobody now depend on a component owned by a company that sells into their accounts.
  • Licensing is genuinely complicated, with different terms for named users, servers, desktop applications and embedded redistribution, so working out what you are allowed to deploy usually requires a conversation rather than reading a document.
  • The free academic package is granted for two-year terms and covers education rather than research, so a research group that assumed it was free discovers it needs a paid commercial academic licence.
  • Nothing is priced publicly for commercial use, so a team evaluating Chemaxon against open source alternatives such as RDKit cannot compare total cost without entering a sales process.
  • Open source cheminformatics has closed much of the functional gap for basic structure handling and search, so the commercial case increasingly rests on prediction quality, support and registration workflows rather than on capability that cannot be obtained elsewhere.

DNAnexus

  • No pricing is published, so an organisation cannot compare the total cost against running the same pipelines on its own cloud account until it is deep in a sales process.
  • Compute and storage are billed through the platform rather than at underlying cloud list price, so the compliance envelope carries a persistent margin on every terabyte and core hour, which grows with the science rather than staying fixed.
  • Data egress at genomic scale is slow and chargeable, so leaving the platform later is a real project rather than a contract decision, and that gravity weakens negotiating position at renewal.
  • The regulated and validated configurations sit in a higher commercial tier than the research configuration, so an organisation that starts in research mode and later needs GxP faces a repricing rather than a setting change.
  • Bioinformaticians used to running Nextflow on their own infrastructure find the platform abstractions constraining, and porting an existing pipeline into the app model is engineering work that does not carry over to any other platform.

Pricing, plan by plan

Chemaxon

On request
  • Academic package$undefined/year
    • Free of charge for education for a two-year term
    • Covers a class including tutor and students, or an applicant faculty
    • Non-commercial research use only
  • Commercial licence$undefined/year
    • Quoted per named user, per server or per redistributed application
    • Toolkits, desktop applications and embedded redistribution licensed separately
    • Annual support and maintenance included in the subscription

DNAnexus

On request
  • DNAnexus Platform$undefined/year
    • Quoted per organisation through a sales process
    • Storage and compute billed through the platform rather than at cloud list price
    • Regulated and validated configurations are a separate commercial tier

Which should you pick?

Choose Chemaxon if

  • You need marvin.
  • You work on Web, Windows, macOS, Linux, On-premise, API.
  • You also want jchem toolkits.
Chemaxon review

Choose DNAnexus if

  • You need governed data storage.
  • You work on Web, Linux.
  • You also want workflow execution.
DNAnexus review

Questions people ask

Is Chemaxon or DNAnexus better?
Neither clearly leads. Chemaxon starts at On request and DNAnexus at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Chemaxon or DNAnexus?
Chemaxon starts at On request and DNAnexus at On request.
Does Chemaxon or DNAnexus run on more platforms?
Chemaxon runs on Web, Windows, macOS, Linux, On-premise, API. DNAnexus runs on Web, Linux.
What is Chemaxon best used for?
Chemaxon is most often used for a software vendor embedding a structure sketcher and search into its own product rather than writing chemistry code, a pharmaceutical informatics team building an internal compound registration system on jchem cartridges, a computational chemistry group needing consistent pka and logd prediction across a screening cascade, a university teaching cheminformatics that can use the free two-year academic package for a class. Of those, a software vendor embedding a structure sketcher and search into its own product rather than writing chemistry code and a pharmaceutical informatics team building an internal compound registration system on jchem cartridges are not what DNAnexus is typically brought in for.
What can Chemaxon do that DNAnexus cannot?
Chemaxon covers Marvin, JChem toolkits, Calculator Plugins, Compound Registration. DNAnexus covers Governed data storage, Workflow execution, App building, Controlled collaboration.

Answered from the vendors’ own pages

Chemaxon: Is Chemaxon still independent?

No. It has been a subsidiary of Certara since October 2024. The products continue under the Chemaxon name.

DNAnexus: Why pay for DNAnexus instead of raw AWS?

For the compliance evidence. GxP, FedRAMP, CLIA, CAP and Part 11 coverage removes a validation programme most organisations would otherwise have to build and maintain themselves.

Chemaxon: Is the academic licence really free?

The education package is free for two-year terms covering a class or faculty. Non-commercial research groups pay a discounted commercial academic licence.

DNAnexus: Is validated use included?

No. Regulated and validated configurations sit in a separate commercial tier from ordinary research use.

Chemaxon: Can I ship Chemaxon inside my own software?

Yes, but embedded redistribution is licensed separately from internal use and must be negotiated.

DNAnexus: Can I get my data out?

Yes, but egress at genomic scale is chargeable and slow, so plan exit costs at the point of signing.

Chemaxon: How does it compare with RDKit?

RDKit is free and covers basic structure handling well. Chemaxon differentiates on property prediction, registration workflows, the sketcher and commercial support.

DNAnexus: Does it host UK Biobank?

Yes, DNAnexus hosts the UK Biobank research analysis platform, which has its own access approval and cost terms.

Share

Related pages

More on Chemaxon

More on DNAnexus

Keep looking

Other head to heads